Grifols SA (GIKLY) stock
GIKLYOTCPharmaceutical PreparationsAlso trades as GIFLF, GIFOF, GRFS
$5.55+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.91BP/E 4.2Yield –
Grifols revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was €7.52B, up 4.3% from the year before. Over ten years it grew 6.7% a year on average. The highest annual figure on record is €7.52B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €7.52B | +4.3% |
| FY2024 | Dec 31, 2024 | €7.21B | +9.4% |
| FY2023 | Dec 31, 2023 | €6.59B | +8.7% |
| FY2022 | Dec 31, 2022 | €6.06B | +22.9% |
| FY2021 | Dec 31, 2021 | €4.93B | -7.6% |
| FY2020 | Dec 31, 2020 | €5.34B | +4.7% |
| FY2019 | Dec 31, 2019 | €5.10B | +13.6% |
| FY2018 | Dec 31, 2018 | €4.49B | +3.9% |
| FY2017 | Dec 31, 2017 | €4.32B | +6.6% |
| FY2016 | Dec 31, 2016 | €4.05B | +2.9% |
| FY2015 | Dec 31, 2015 | €3.93B | – |
See a number that looks wrong?